Siemens Healthineers (SMMNY) Projected to Post Quarterly Earnings on Friday

Siemens Healthineers (OTCMKTS:SMMNY) will likely be announcing its resultson Friday, July 31st. Analysts expect the company to post earnings of $0.3022 per share and revenue of $6.4503 billion for the quarter.

Siemens Healthineers (OTCMKTS:SMMNY) last issued its earnings results on Thursday, May 7th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.29 by $0.02. The business had revenue of $6.68 billion for the quarter, compared to analyst estimates of $6.96 billion.

Siemens Healthineers Price Performance

SMMNY stock opened at $19.32 on Friday. The firm has a 50-day moving average price of $19.84 and a 200-day moving average price of $22.04. Siemens Healthineers has a 12 month low of $19.20 and a 12 month high of $28.92.

Wall Street Analyst Weigh In

Separately, Zacks Research downgraded shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research note on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Siemens Healthineers presently has a consensus rating of “Moderate Buy”.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.